Enhancing the understanding of financial toxicity in people with cancer in Australia: Instrument development and validation

Financial toxicity (FT) is increasingly recognised as a common distressing effect following a cancer diagnosis in Australia and globally.

A validated, comprehensive Patient-Reported Outcome (PRO) measure for subjectively assessing FT suitable for the Australian healthcare system is lacking.